Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 426


Protective role for the N-terminal domain of α-dystroglycan in Influenza A virus proliferation.

de Greef JC, Slütter B, Anderson ME, Hamlyn R, O'Campo Landa R, McNutt EJ, Hara Y, Pewe LL, Venzke D, Matsumura K, Saito F, Harty JT, Campbell KP.

Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11396-11401. doi: 10.1073/pnas.1904493116. Epub 2019 May 16.


Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.

Beltrán D, Anderson ME, Bharathy N, Settelmeyer TP, Svalina MN, Bajwa Z, Shern JF, Gultekin SH, Cuellar MA, Yonekawa T, Keller C, Campbell KP.

Skelet Muscle. 2019 May 4;9(1):11. doi: 10.1186/s13395-019-0195-0.


Clinical utility of RNA sequencing to resolve unusual GNE myopathy with a novel promoter deletion.

Chakravorty S, Berger K, Arafat D, Nallamilli BRR, Subramanian HP, Joseph S, Anderson ME, Campbell KP, Glass J, Gibson G, Hegde M.

Muscle Nerve. 2019 Jul;60(1):98-103. doi: 10.1002/mus.26486. Epub 2019 Apr 29.


Dynamic Dystroglycan Complexes Mediate Cell Entry of Lassa Virus.

Herrador A, Fedeli C, Radulovic E, Campbell KP, Moreno H, Gerold G, Kunz S.

MBio. 2019 Mar 26;10(2). pii: e02869-18. doi: 10.1128/mBio.02869-18.


Biochemical and pathological changes result from mutated Caveolin-3 in muscle.

González Coraspe JA, Weis J, Anderson ME, Münchberg U, Lorenz K, Buchkremer S, Carr S, Zahedi RP, Brauers E, Michels H, Sunada Y, Lochmüller H, Campbell KP, Freier E, Hathazi D, Roos A.

Skelet Muscle. 2018 Aug 28;8(1):28. doi: 10.1186/s13395-018-0173-y.


Uniparental disomy unveils a novel recessive mutation in POMT2.

Brun BN, Willer T, Darbro BW, Gonorazky HD, Naumenko S, Dowling JJ, Campbell KP, Moore SA, Mathews KD.

Neuromuscul Disord. 2018 Jul;28(7):592-596. doi: 10.1016/j.nmd.2018.04.003. Epub 2018 Apr 10.


Dystroglycan Maintains Inner Limiting Membrane Integrity to Coordinate Retinal Development.

Clements R, Turk R, Campbell KP, Wright KM.

J Neurosci. 2017 Aug 30;37(35):8559-8574. doi: 10.1523/JNEUROSCI.0946-17.2017. Epub 2017 Jul 31.


Exome sequencing reveals independent SGCD deletions causing limb girdle muscular dystrophy in Boston terriers.

Cox ML, Evans JM, Davis AG, Guo LT, Levy JR, Starr-Moss AN, Salmela E, Hytönen MK, Lohi H, Campbell KP, Clark LA, Shelton GD.

Skelet Muscle. 2017 Jul 11;7(1):15. doi: 10.1186/s13395-017-0131-0.


Structure of protein O-mannose kinase reveals a unique active site architecture.

Zhu Q, Venzke D, Walimbe AS, Anderson ME, Fu Q, Kinch LN, Wang W, Chen X, Grishin NV, Huang N, Yu L, Dixon JE, Campbell KP, Xiao J.

Elife. 2016 Nov 23;5. pii: e22238. doi: 10.7554/eLife.22238.


Biallelic Mutations in TMTC3, Encoding a Transmembrane and TPR-Containing Protein, Lead to Cobblestone Lissencephaly.

Jerber J, Zaki MS, Al-Aama JY, Rosti RO, Ben-Omran T, Dikoglu E, Silhavy JL, Caglar C, Musaev D, Albrecht B, Campbell KP, Willer T, Almuriekhi M, Çağlayan AO, Vajsar J, Bilgüvar K, Ogur G, Abou Jamra R, Günel M, Gleeson JG.

Am J Hum Genet. 2016 Nov 3;99(5):1181-1189. doi: 10.1016/j.ajhg.2016.09.007. Epub 2016 Oct 20.


Neuronal Dystroglycan Is Necessary for Formation and Maintenance of Functional CCK-Positive Basket Cell Terminals on Pyramidal Cells.

Früh S, Romanos J, Panzanelli P, Bürgisser D, Tyagarajan SK, Campbell KP, Santello M, Fritschy JM.

J Neurosci. 2016 Oct 5;36(40):10296-10313.


Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle.

Rader EP, Turk R, Willer T, Beltrán D, Inamori K, Peterson TA, Engle J, Prouty S, Matsumura K, Saito F, Anderson ME, Campbell KP.

Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):10992-7. doi: 10.1073/pnas.1605265113. Epub 2016 Sep 13.


Structural basis of laminin binding to the LARGE glycans on dystroglycan.

Briggs DC, Yoshida-Moriguchi T, Zheng T, Venzke D, Anderson ME, Strazzulli A, Moracci M, Yu L, Hohenester E, Campbell KP.

Nat Chem Biol. 2016 Oct;12(10):810-4. doi: 10.1038/nchembio.2146. Epub 2016 Aug 15.


LARGE2-dependent glycosylation confers laminin-binding ability on proteoglycans.

Inamori KI, Beedle AM, de Bernabé DB, Wright ME, Campbell KP.

Glycobiology. 2016 Dec;26(12):1284-1296. Epub 2016 Jul 22.


The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition.

Praissman JL, Willer T, Sheikh MO, Toi A, Chitayat D, Lin YY, Lee H, Stalnaker SH, Wang S, Prabhakar PK, Nelson SF, Stemple DL, Moore SA, Moremen KW, Campbell KP, Wells L.

Elife. 2016 Apr 29;5. pii: e14473. doi: 10.7554/eLife.14473.


A Transitional Care Model Using Faith Community Nurses.

Ziebarth D, Campbell KP.

J Christ Nurs. 2016 Apr-Jun;33(2):112-8.


Molecular Signatures of Membrane Protein Complexes Underlying Muscular Dystrophy.

Turk R, Hsiao JJ, Smits MM, Ng BH, Pospisil TC, Jones KS, Campbell KP, Wright ME.

Mol Cell Proteomics. 2016 Jun;15(6):2169-85. doi: 10.1074/mcp.M116.059188. Epub 2016 Apr 20.


Collagen VI deficiency reduces muscle pathology, but does not improve muscle function, in the γ-sarcoglycan-null mouse.

de Greef JC, Hamlyn R, Jensen BS, O'Campo Landa R, Levy JR, Kobuke K, Campbell KP.

Hum Mol Genet. 2016 Apr 1;25(7):1357-69. doi: 10.1093/hmg/ddw018. Epub 2016 Jan 24.


Training the next generation of biomedical investigators in glycosciences.

Agre P, Bertozzi C, Bissell M, Campbell KP, Cummings RD, Desai UR, Estes M, Flotte T, Fogleman G, Gage F, Ginsburg D, Gordon JI, Hart G, Hascall V, Kiessling L, Kornfeld S, Lowe J, Magnani J, Mahal LK, Medzhitov R, Roberts RJ, Sackstein R, Sarkar R, Schnaar R, Schwartz N, Varki A, Walt D, Weissman I.

J Clin Invest. 2016 Feb;126(2):405-8. doi: 10.1172/JCI85905. Epub 2016 Feb 1. Review.


Genetic characterization and improved genotyping of the dysferlin-deficient mouse strain Dysf (tm1Kcam).

Wiktorowicz T, Kinter J, Kobuke K, Campbell KP, Sinnreich M.

Skelet Muscle. 2015 Oct 13;5:32. doi: 10.1186/s13395-015-0057-3. eCollection 2015.


GMPPB-Associated Dystroglycanopathy: Emerging Common Variants with Phenotype Correlation.

Jensen BS, Willer T, Saade DN, Cox MO, Mozaffar T, Scavina M, Stefans VA, Winder TL, Campbell KP, Moore SA, Mathews KD.

Hum Mutat. 2015 Dec;36(12):1159-63. doi: 10.1002/humu.22898. Epub 2015 Sep 23.


Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.

Yoshida-Moriguchi T, Campbell KP.

Glycobiology. 2015 Jul;25(7):702-13. doi: 10.1093/glycob/cwv021. Epub 2015 Apr 16. Review.


The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation.

Willer T, Inamori K, Venzke D, Harvey C, Morgensen G, Hara Y, Beltrán Valero de Bernabé D, Yu L, Wright KM, Campbell KP.

Elife. 2014 Oct 3;3. doi: 10.7554/eLife.03941.


Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.

Inamori K, Willer T, Hara Y, Venzke D, Anderson ME, Clarke NF, Guicheney P, Bönnemann CG, Moore SA, Campbell KP.

J Biol Chem. 2014 Oct 10;289(41):28138-48. doi: 10.1074/jbc.M114.597831. Epub 2014 Aug 19.


Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage.

Lin SS, Tzeng BH, Lee KR, Smith RJ, Campbell KP, Chen CC.

Proc Natl Acad Sci U S A. 2014 May 13;111(19):E1990-8. doi: 10.1073/pnas.1323112111. Epub 2014 Apr 28.


A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutations.

Wallace SE, Conta JH, Winder TL, Willer T, Eskuri JM, Haas R, Patterson K, Campbell KP, Moore SA, Gospe SM Jr.

Neuromuscul Disord. 2014 Apr;24(4):312-20. doi: 10.1016/j.nmd.2014.01.001. Epub 2014 Jan 11.


Skeletal muscle's 3rd year anniversary.

Glass DJ, Campbell KP, Rudnicki MA.

Skelet Muscle. 2014 Jan 24;4(1):3. doi: 10.1186/2044-5040-4-3. No abstract available.


Glial scaffold required for cerebellar granule cell migration is dependent on dystroglycan function as a receptor for basement membrane proteins.

Nguyen H, Ostendorf AP, Satz JS, Westra S, Ross-Barta SE, Campbell KP, Moore SA.

Acta Neuropathol Commun. 2013 Sep 6;1:58. doi: 10.1186/2051-5960-1-58.


MG53's new identity.

Levy JR, Campbell KP, Glass DJ.

Skelet Muscle. 2013 Nov 1;3(1):25. doi: 10.1186/2044-5040-3-25.


LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy.

Goddeeris MM, Wu B, Venzke D, Yoshida-Moriguchi T, Saito F, Matsumura K, Moore SA, Campbell KP.

Nature. 2013 Nov 7;503(7474):136-40. doi: 10.1038/nature12605. Epub 2013 Oct 16.


SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function.

Yoshida-Moriguchi T, Willer T, Anderson ME, Venzke D, Whyte T, Muntoni F, Lee H, Nelson SF, Yu L, Campbell KP.

Science. 2013 Aug 23;341(6148):896-9. doi: 10.1126/science.1239951. Epub 2013 Aug 8.


Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy.

Yang AC, Ng BG, Moore SA, Rush J, Waechter CJ, Raymond KM, Willer T, Campbell KP, Freeze HH, Mehta L.

Mol Genet Metab. 2013 Nov;110(3):345-351. doi: 10.1016/j.ymgme.2013.06.016. Epub 2013 Jun 28.


Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan.

Carss KJ, Stevens E, Foley AR, Cirak S, Riemersma M, Torelli S, Hoischen A, Willer T, van Scherpenzeel M, Moore SA, Messina S, Bertini E, Bönnemann CG, Abdenur JE, Grosmann CM, Kesari A, Punetha J, Quinlivan R, Waddell LB, Young HK, Wraige E, Yau S, Brodd L, Feng L, Sewry C, MacArthur DG, North KN, Hoffman E, Stemple DL, Hurles ME, van Bokhoven H, Campbell KP, Lefeber DJ; UK10K Consortium, Lin YY, Muntoni F.

Am J Hum Genet. 2013 Jul 11;93(1):29-41. doi: 10.1016/j.ajhg.2013.05.009. Epub 2013 Jun 13.


Illuminating regeneration: noninvasive imaging of disease progression in muscular dystrophy.

Levy JR, Campbell KP.

J Clin Invest. 2013 May;123(5):1931-4. doi: 10.1172/JCI69568. Epub 2013 Apr 24.


Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.

Stevens E, Carss KJ, Cirak S, Foley AR, Torelli S, Willer T, Tambunan DE, Yau S, Brodd L, Sewry CA, Feng L, Haliloglu G, Orhan D, Dobyns WB, Enns GM, Manning M, Krause A, Salih MA, Walsh CA, Hurles M, Campbell KP, Manzini MC; UK10K Consortium, Stemple D, Lin YY, Muntoni F.

Am J Hum Genet. 2013 Mar 7;92(3):354-65. doi: 10.1016/j.ajhg.2013.01.016. Epub 2013 Feb 28.


ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies.

Cirak S, Foley AR, Herrmann R, Willer T, Yau S, Stevens E, Torelli S, Brodd L, Kamynina A, Vondracek P, Roper H, Longman C, Korinthenberg R, Marrosu G, Nürnberg P; UK10K Consortium, Michele DE, Plagnol V, Hurles M, Moore SA, Sewry CA, Campbell KP, Voit T, Muntoni F.

Brain. 2013 Jan;136(Pt 1):269-81. doi: 10.1093/brain/aws312. Epub 2013 Jan 3.


Cell entry of Lassa virus induces tyrosine phosphorylation of dystroglycan.

Moraz ML, Pythoud C, Turk R, Rothenberger S, Pasquato A, Campbell KP, Kunz S.

Cell Microbiol. 2013 May;15(5):689-700. doi: 10.1111/cmi.12078. Epub 2012 Dec 20.


Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.

Esser AK, Miller MR, Huang Q, Meier MM, Beltran-Valero de Bernabé D, Stipp CS, Campbell KP, Lynch CF, Smith BJ, Cohen MB, Henry MD.

J Biol Chem. 2013 Jan 25;288(4):2132-42. doi: 10.1074/jbc.M112.432807. Epub 2012 Dec 6.


An HMGA2-IGF2BP2 axis regulates myoblast proliferation and myogenesis.

Li Z, Gilbert JA, Zhang Y, Zhang M, Qiu Q, Ramanujan K, Shavlakadze T, Eash JK, Scaramozza A, Goddeeris MM, Kirsch DG, Campbell KP, Brack AS, Glass DJ.

Dev Cell. 2012 Dec 11;23(6):1176-88. doi: 10.1016/j.devcel.2012.10.019. Epub 2012 Nov 21. Erratum in: Dev Cell. 2013 Jan 14;24(1):112.


Dystroglycan on radial glia end feet is required for pial basement membrane integrity and columnar organization of the developing cerebral cortex.

Myshrall TD, Moore SA, Ostendorf AP, Satz JS, Kowalczyk T, Nguyen H, Daza RA, Lau C, Campbell KP, Hevner RF.

J Neuropathol Exp Neurol. 2012 Dec;71(12):1047-63. doi: 10.1097/NEN.0b013e318274a128.


Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2.

Inamori K, Hara Y, Willer T, Anderson ME, Zhu Z, Yoshida-Moriguchi T, Campbell KP.

Glycobiology. 2013 Mar;23(3):295-302. doi: 10.1093/glycob/cws152. Epub 2012 Nov 2.


Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy.

Beedle AM, Turner AJ, Saito Y, Lueck JD, Foltz SJ, Fortunato MJ, Nienaber PM, Campbell KP.

J Clin Invest. 2012 Sep;122(9):3330-42. doi: 10.1172/JCI63004. Epub 2012 Aug 27.


ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.

Willer T, Lee H, Lommel M, Yoshida-Moriguchi T, de Bernabe DB, Venzke D, Cirak S, Schachter H, Vajsar J, Voit T, Muntoni F, Loder AS, Dobyns WB, Winder TL, Strahl S, Mathews KD, Nelson SF, Moore SA, Campbell KP.

Nat Genet. 2012 May;44(5):575-80. doi: 10.1038/ng.2252.


Binding of Lassa virus perturbs extracellular matrix-induced signal transduction via dystroglycan.

Rojek JM, Moraz ML, Pythoud C, Rothenberger S, Van der Goot FG, Campbell KP, Kunz S.

Cell Microbiol. 2012 Jul;14(7):1122-34. doi: 10.1111/j.1462-5822.2012.01784.x. Epub 2012 Apr 4.


Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE.

Inamori K, Yoshida-Moriguchi T, Hara Y, Anderson ME, Yu L, Campbell KP.

Science. 2012 Jan 6;335(6064):93-6. doi: 10.1126/science.1214115.


Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of LAMA2.

Di Blasi C, Bellafiore E, Salih MA, Manzini MC, Moore SA, Seidahmed MZ, Mukhtar MM, Karrar ZA, Walsh CA, Campbell KP, Mantegazza R, Morandi L, Mora M.

BMC Res Notes. 2011 Dec 13;4:534. doi: 10.1186/1756-0500-4-534.


Endpoint measures in the mdx mouse relevant for muscular dystrophy pre-clinical studies.

Kobayashi YM, Rader EP, Crawford RW, Campbell KP.

Neuromuscul Disord. 2012 Jan;22(1):34-42. doi: 10.1016/j.nmd.2011.08.001. Epub 2011 Dec 10.


Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice.

Han R, Rader EP, Levy JR, Bansal D, Campbell KP.

Skelet Muscle. 2011 Dec 1;1(1):35. doi: 10.1186/2044-5040-1-35.


Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.

Hara Y, Kanagawa M, Kunz S, Yoshida-Moriguchi T, Satz JS, Kobayashi YM, Zhu Z, Burden SJ, Oldstone MB, Campbell KP.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17426-31. doi: 10.1073/pnas.1114836108. Epub 2011 Oct 10.


Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex.

Lancioni A, Rotundo IL, Kobayashi YM, D'Orsi L, Aurino S, Nigro G, Piluso G, Acampora D, Cacciottolo M, Campbell KP, Nigro V.

Hum Mol Genet. 2011 Dec 1;20(23):4644-54. doi: 10.1093/hmg/ddr398. Epub 2011 Sep 2.

Supplemental Content

Loading ...
Support Center